Diabetes is a chronic disease that demands lifelong management. It impacts all age groups — children, and young and older adults — and if not managed properly, there can be devastating consequences. Lack of access to insulin for people with type 1 diabetes is fatal. MSF currently treats people living…

It is often said that Innovation and Access are two sides to the same coin when it comes to ensuring that people in developing countries are able to get the healthcare products they need to stay alive and well. And it is through the lens of these two complementary activities…

With the United Nations High-Level meeting just over the horizon, the TB community is ready to amplify the voices of people affected by TB around the world at this global forum, and demand the global attention and resources needed to beat this devastating yet curable disease. In this blog, Christophe…

Every child who dies from a preventable disease is a failure of the system and an attack on the basic human rights of children everywhere Miriam Alía, Vaccination and Outbreak Response Advisor, Médecins Sans Frontières It is a shocking fact that approximately half of all children born in Syria in…

By Zhenyan Zhu, Yuanqiong Hu, and Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift…

Dr Zulfiya Dustmatova works as a medical doctor with MSF in Tajikistan, where our teams work with the Ministry of Health and Social Protection to diagnose and treat children with drug-resistant TB (DR-TB). MSF first began treating children with drug resistant TB in Tajikistan in 2012. At that time, we…

By Julien Potet, Senior Advisor, Tropical Diseases and Neglected Diseases, MSF Access Campaign Some diseases are more neglected than others. This is the case with snakebites, which are responsible for more than 100,000 deaths every year worldwide. A recent MSF publication in Toxicon X highlights the resources needed to improve…

In late 2022, science delivered when we shared the stunning results of a five-year clinical trial for a groundbreaking new treatment regimen for people living with drug-resistant TB. Ahead in 2023, we are looking forward to seeing the benefits to people’s lives as the treatment is rolled out in MSF…

Today MSF is publicly announcing its Clinical Trial Transparency Policy (CTTP). Transparency is one of MSF’s five working principles, alongside impartiality, independence, neutrality and bearing witness, which are all key to support the delivery of our medical humanitarian mission. MSF is involved in a number of clinical trials, and as…